Company Filing History:
Years Active: 2018
Title: Michel Ducreux: Innovator in Lung Cancer Treatment
Introduction
Michel Ducreux is a notable inventor based in Vanves, France. He has made significant contributions to the field of cancer treatment through his innovative approaches. His work focuses on improving the efficacy of drug treatments for lung cancer, showcasing his commitment to advancing medical science.
Latest Patents
Michel Ducreux holds a patent for "Computer implemented methods of treating lung cancer." This invention involves a method for predicting the relative efficacy of various drugs for treating tumors in individuals. The process includes the molecular characterization of the tumor and the calculation of a score for the drugs based on the percentage of deregulated target genes. This patent highlights his dedication to enhancing treatment options for patients suffering from lung cancer.
Career Highlights
Ducreux is associated with Worldwide Innovative Network, where he applies his expertise to develop groundbreaking solutions in oncology. His career reflects a strong focus on integrating technology with medical research to improve patient outcomes.
Collaborations
Throughout his career, Michel has collaborated with esteemed colleagues, including Vladimir Lazar and Jean-Charles Soria. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michel Ducreux's contributions to lung cancer treatment through his patented methods exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds the potential to improve the lives of many patients.